Home / Stocks / SCTX

SCTX insider trading

Scribe Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$71.3M
Buys · last 90 days
6 · $71.3M
Most recent buy
2026-07-29

Cluster buy detected

6 insiders bought SCTX within a short window (2026-07-23→2026-07-27), $71.3M in total — cluster score 100/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-29AH Bio Fund II, L.P.cluster
10% owner
Bought333,333$15.00$5.0M
2026-07-29GORDON CARL Lcluster
Director
Bought1,000,000$15.00$15.0M
2026-07-29ORBIMED ADVISORS LLCcluster
Director
Bought1,000,000$15.00$15.0M
2026-07-28Aghazadeh Behzadcluster
Director · 10% owner
Bought2,391,238$15.16$36.3M
2026-07-27Lucas Svetlanacluster
Chief Business Officer
Bought3,000$15.00$45k
2026-07-27Parrot Davidcluster
Chief Financial Officer
Bought2,666$15.00$40k

Most active insider buyers

InsiderRoleBuysTotal bought
Aghazadeh BehzadDirector · 10% owner1$36.3M
GORDON CARL LDirector1$15.0M
ORBIMED ADVISORS LLCDirector1$15.0M
AH Bio Fund II, L.P.10% owner1$5.0M
Lucas SvetlanaChief Business Officer1$45k
Parrot DavidChief Financial Officer1$40k

See SCTX on the chart

Every insider buy and sell for SCTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.